Lin Zhengyue-e said earlier that it has reached a procurement agreement with pharmaceutical companies for three new crown vaccines, including China Kexing vaccine, German pharmaceutical company BioNTech/Pfizer/Fosun mRNA vaccine, and the University of Oxford participated in the research and development of AstraZeneca vaccine. Carrie Lam said earlier that citizens cannot choose the type of vaccine.
Executive Council member Lin Jianfeng said that the procurement and distribution of vaccines are government actions and arrangements. According to his understanding, the government’s approach is to arrange for certain hospitals and clinics to vaccinate the citizens with one of these vaccines, and another batch of hospital clinics to vaccinate the other vaccines. The distribution of vaccines will be transparent. Which vaccine to vaccinate, that is, if citizens want to be vaccinated with domestically produced Kexing or Huiduan vaccines, they can freely choose to vaccinate at a specific location. They have freedom of choice in disguise. Lin Jianfeng said that different vaccines have different temperature storage requirements, and it is difficult to require a hospital clinic to process different vaccines at the same time.
New crown vaccine related reports:
Vaccine allergy material excipients cause doctors to call for legislation to list ingredients
US media: Kexing vaccine passes the effective threshold in Brazil
Confirmed cases of new coronary pneumonia:
coronavirus disease Death cases:
Coronavirus pneumonia and other reports:
–